Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7060688
Products and methods for controlling the suppression of the neoplastic phenotype
granted -
US 7060733
Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species
granted -
US 7056901
Microgel particles for the delivery of bioactive materials
granted -
US 7056506
Methods for detecting and inhibiting angiogenesis
granted -
US 7056501
Recombinant neospora antigens and their uses
granted -
US 7056945
Selective inhibition of neuronal nitric oxide synthase
granted -
US 7053263
Mouse models of human prostate cancer progression
granted -
US 7052674
Prokineticin polypeptides, related compositions and methods
granted -
US 7052856
NELL-1 enhanced bone mineralization
granted -
US 7053119
Methods for identifying and using IKK inhibitors
granted -
US 7045337
In vivo incorporation of unnatural amino acids
expired -
US 7045283
Methods of high-throughput screening for internalizing antibodies
expired -
US 7045326
Mono- and diacylglycerol acyltransferases and methods of use thereof
expired -
US 7041481
Chemical amplification based on fluid partitioning
expired -
US 7041806
Netrin receptors
expired -
US 7041462
Conformational and topological protein regulation
expired -
US 7037901
Radiosensitization by indolocarbazole derivatives
expired -
US 7034014
Phosphonate compounds
expired -
US 7029911
AFC1 and RCE1: isoprenylated CAAX processing enzymes
expired -
US 7029652
Method of treating tumors
expired -
US 7030232
E25A protein, methods for producing and use thereof
expired -
US 7030080
Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof
expired -
US 7026155
Method of reducing bacterial proliferation
expired -
US 7022882
NMDA receptor channel blocker with neuroprotective activity
expired